Scalper1 News
Medical spending tends to rise steadily, but drug stocks can see huge swings as clinical trials, FDA reviews and other news buoy or torpedo the outlook. This week’s 5 big drug winners* rallied for diverse reasons. KaloBios Pharmaceuticals (KBIO) skyrocketed as new buyers stepped in before liquidation. Valeant Pharmaceuticals (VRX) rebounded after a huge sell-off. Sarepta Therapeutics (SRPT) benefited from a rival’s bad news. Voyager Therapeutics Scalper1 News
Scalper1 News